mBioMicrobiologyPeer-reviewed journal article
Osmotic conditions shape fitness gains and resistance mechanisms during E. coli and T4 phage co-evolution
Michael HunteriD, Eric Lyall, Kriti VermaiD, Carolina TropiniiD
Abstract
Environmental conditions strongly influence interactions between bacteria and bacterio-phages (phages). Here, we examined how osmolality (solute concentration) shapes the in vitro co-evolution of T4 phage and its host Escherichia coli during serial passage. When evolved independently, we observed substantial fitness gains in both bacteria and phages, particularly in high osmotic conditions. During co-evolution, however, fitness gains were limited, bacterial populations consistently evolved phage resistance, and several phage populations went extinct. Furthermore, the resistance mechanisms varied by osmolality. In lower osmolalities, mutations disrupted phage binding sites, conferring strong resistance. In higher osmolalities, mutations led to increased colonic acid production, producing a mucoid phenotype with weaker resistance. Because mucoidy has been associated with increased bacterial virulence, these findings suggest that gut-relevant osmotic conditions may constrain evolutionary trajectories, favoring resistance strategies that are less effective against phage but potentially more virulent, with important implications for phage therapy design. SignificancePhages offer a promising alternative to antibiotics, but their safety and efficacy strongly depends on the environmental conditions where the bacteria and phages interact. In the human gut, for instance, solute concentrations can vary widely due to factors like food intolerances or laxative use. In this study, we show that such variations significantly impact how bacteria and phages co-evolve. In particular, we find that in higher osmolalities, bacteria evolve phage resistance through mucoidy - a phenotype linked with increased bacterial virulence - rather than receptor loss. This highlights the need to consider environmental factors when developing phage therapies.
- organism: E. coli
- assay: proteomics
- assay: metagenomics
- research focus: host-pathogen & immune response
- research focus: development & morphogenesis
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 3
- FWCI
- 10.40
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SUB-OPTIMAL ENVIRONMENTAL CONDITIONS PROLONG PHAGE EPIDEMICS IN BACTERIAL POPULATIONS
H. Goehlich, O. Roth, … C. C. Wendling·bioRxiv·Oct 28, 2022
- Bacteria-phage (co)evolution is constrained in a synthetic community across multiple bacteria-phage pairs
Meaghan Castledine, Daniel Padfield, … Angus G. J. Buckling·MicrobiologyPeer-reviewed·Jun 19, 2025
- Bacteriophage density influences the rate of resistance evolution
Tuan Anh Phan, Anuja Shrestha, … James T. Van Leuven·Bulletin of Mathematical BiologyPeer-reviewed·Aug 20, 2026
- Phenotypic heterogeneity drives phage-bacteria coevolution in the intestinal tract
N. Wenner, A. Bertola, … M. Diard·bioRxiv·Nov 8, 2023
- Sex overrides mutation in Escherichia coli colonizing the gut
- Parallel evolution of phage resistance - virulence trade - offs during in vitro and nasal Pseudomonas aeruginosa phage treatment
M. Castledine, D. Padfield, … A. Buckling·bioRxiv·Sep 6, 2021